2% chlorhexidine–70% isopropyl alcohol versus 10% povidone–iodine for insertion site cleaning before central line insertion in preterm infants: a randomised trial
| Autor: | A Twomey, Anne O’Sullivan, Emily A Kieran, Colm P F O'Donnell, Jan Miletin, Susan J Knowles |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
Catheterization Central Venous medicine.medical_specialty chemistry.chemical_element Gestational Age Insertion site Iodine Skin Diseases law.invention 2-Propanol 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Randomized controlled trial law Intensive Care Units Neonatal 030225 pediatrics Intensive care medicine Humans 030212 general & internal medicine Povidone-Iodine business.industry Chlorhexidine Infant Newborn Obstetrics and Gynecology Isopropyl alcohol General Medicine Surgery Clinical trial Catheter chemistry Catheter-Related Infections Anesthesia Pediatrics Perinatology and Child Health Anti-Infective Agents Local Female business Infant Premature medicine.drug |
| Zdroj: | Archives of Disease in Childhood - Fetal and Neonatal Edition. 103:F101-F106 |
| ISSN: | 1468-2052 1359-2998 |
| DOI: | 10.1136/archdischild-2016-312193 |
| Popis: | ObjectiveTo determine whether 2% chlorhexidine gluconate–70% isopropyl alcohol (CHX–IA) is superior to 10% aqueous povidone–iodine (PI) in preventing catheter-related blood stream infection (CR-BSI) when used to clean insertion sites before placing central venous catheters (CVCs) in preterm infants.DesignRandomised controlled trial.SettingTwo neonatal intensive care units (NICUs).PatientsInfants InterventionsInsertion site was cleaned with CHX–IA or PI. Caregivers were not masked to group assignment.Main outcome measuresPrimary outcome was CR-BSI determined by one microbiologist who was masked to group assignment. Secondary outcomes included skin reactions to study solution and thyroid dysfunction.ResultsWe enrolled 304 infants (CHX–IA 148 vs PI 156) in whom 815 CVCs (CHX–IA 384 vs PI 431) were inserted and remained in situ for 3078 (CHX–IA 1465 vs PI 1613) days. We found no differences between the groups in the proportion of infants with CR-BSI (CHX–IA 7% vs PI 5%, p=0.631), the proportion of CVCs complicated by CR-BSI or the rate of CR-BSI per 1000 catheter days. Skin reaction rates were low (ConclusionsWe did not find a difference in the rate of CR-BSI between preterm infants treated with CHX–IA and PI, and more infants treated with PI had thyroid dysfunction. However, our study was not adequately powered to detect a difference in our primary outcome and a larger trial is required to confirm our findings.Trial registrationThis study was registered with the EU clinical trials register before the first patient was enrolled (Eudract 2011-002962-19). (https://www.clinicaltrialsregister.eu) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|